Improving diagnosis of infectious diseases using advanced PCR technology
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning
This study is working on a new way to quickly and accurately identify different germs that cause infections, so patients can get the right treatment faster and with fewer unnecessary tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11082439 on NIH RePORTER |
What this research studies
This research focuses on developing a new diagnostic method for infectious diseases that can accurately identify multiple pathogens simultaneously. By utilizing digital PCR (dPCR), the approach aims to provide precise measurements of pathogen concentrations, which is crucial for determining the actual cause of infections. Unlike traditional methods that often yield false positives, this technique enhances diagnostic accuracy and reduces the need for additional testing. Patients will benefit from faster and more reliable diagnoses, leading to more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing symptoms of infectious diseases that require precise diagnosis.
Not a fit: Patients with infections that are already well-characterized and do not require advanced diagnostic methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of infectious diseases, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using digital PCR for pathogen detection, indicating that this approach could be a significant advancement in diagnostics.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Abate, Adam R. — University of California, San Francisco
- Study coordinator: Abate, Adam R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.